Alembic Pharmaceuticals gets FDA final approval for Doxepin Hydrochloride Capsules
Alembic Pharmaceuticals announces USFDA Final Approval for Doxepin Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg, 75 mg and 100 mg. Alembic Pharmaceuticals has secured final approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Doxepin Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg, 75 […]